Orser Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$1.99M |
| 2 |
Invesco S&P SmallCap Health Care ETF
PSCH
|
+$237K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
|
+$7.74M |
| 2 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$2.15M |
| 3 |
CELG
Celgene Corp
CELG
|
+$1.62M |
| 4 |
Bank of America
BAC
|
+$1.56M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$1.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.98% |
| 2 | Healthcare | 16.89% |
| 3 | Industrials | 11.77% |
| 4 | Consumer Staples | 8.35% |
| 5 | Consumer Discretionary | 7.4% |
Similar funds
Orser Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Orser Capital Management held 85 positions worth $86.8M, down 17% from $104M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Orser Capital Management withdrew a net $17.6M in Q4 2018, closing 14 positions and reducing 1 holding. Its most notable exit was State Street SPDR Bloomberg Investment Grade Floating Rate ETF, an estimated $7.74M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Orser Capital Management opened a new position in Edwards Lifesciences worth $1.93M.
- Orser Capital Management's largest Q4 2018 buy was Edwards Lifesciences: 39,330 shares worth $1.93M.
- Orser Capital Management's biggest Q4 2018 reduction was Honeywell, cutting an estimated $35.1K.
- Orser Capital Management fully exited State Street SPDR Bloomberg Investment Grade Floating Rate ETF in Q4 2018, selling an estimated $7.74M.
- Orser Capital Management's ten largest holdings make up 33% of its $86.8M portfolio in Q4 2018.
- Orser Capital Management opened 2 new positions and closed 14 in Q4 2018.
- Orser Capital Management's portfolio value fell 17% quarter-over-quarter to $86.8M.
Based on Orser Capital Management's 13F filing for Q4 2018, filed 14 Nov 2019.